The results showed, despite no changes in the total Akt quantity, a significant decrease of p[Thr308]Akt in 6-month-old placebo-treated 3×Tg-AD mice in comparison with placebo-treated Non-Tg littermates. This evidence concerns the gene AKT1 and Alzheimer disease.